Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 7/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CASP4 | P49662 | 1/20 | 0.40 |
| ▸ | CASP5 | P51878 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Minoxidil SCHEMBL29698 | 0.98 | SMN1; SMN2 (0.47) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL638820 | 0.98 | SMN1; SMN2 (0.47) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL8860979 | 0.98 | SMN1; SMN2 (0.47) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL29365549 | 0.98 | SMN1; SMN2 (0.47) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL6242048 | 0.97 | SMN1; SMN2 (0.46) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL3137104 | 0.97 | SMN1; SMN2 (0.46) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL8080441 | 0.97 | SMN1; SMN2 (0.46) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL7634414 | 0.97 | SMN1; SMN2 (0.46) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL5080820 | 0.97 | SMN1; SMN2 (0.46) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 | |
| Minoxidil SCHEMBL22189162 | 0.91 | SMN1; SMN2 (0.42) | HRH4SMN1; SMN2CRHBPCRHR2NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131459-A | Anti-hair loss essence and preparation method thereof | 广东凯乐生物技术有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120131597-A | Alopecia preventing composition and application thereof | 广东凯乐生物技术有限公司 | 2025-06-13 | — | — | CN | claimed |
| WO-2025110928-A1 | COMPOUNDS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-05-30 | — | — | WO | claimed |
| CN-118480007-B | Synthesis process of comparable drops | 华泰民康(沈阳)科技有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118480007-A | Synthesis process of comparable drops | 华泰民康(沈阳)科技有限公司 | 2024-08-13 | — | — | CN | claimed |
| US-10016351-B2 | Composition for promoting hair growth or preventing hair loss | NEOPHARM CO., LTD. (KR) | 2018-07-10 | — | — | US | claimed |
| CN-104955460-B | Emulsification composition | 富士胶片株式会社 | 2018-06-19 | — | — | CN | claimed |
| US-20170239164-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH OR PREVENTING HAIR LOSS | NEOPHARM CO., LTD. (KR) | 2017-08-24 | — | — | US | claimed |
| CN-105658204-A | Method for physically encapsulating, in hydrogel particle, liposome containing active ingredient, and cosmetic composition containing same | 华斯泰株式会社 | 2016-06-08 | — | — | CN | claimed |
| WO-2007046577-A1 | EXTERNAL COMPOSITION FOR HAIR GROWTH | AMOREPACIFIC CORPORATION (KR) | 2007-04-26 | — | — | WO | claimed |
| CN-120131459-B | Anti-hair loss essence and preparation method thereof | 广东凯乐生物技术有限公司 | 2026-01-16 | — | — | CN | disclosed |
| CN-120131597-B | Alopecia preventing composition and application thereof | 广东凯乐生物技术有限公司 | 2025-09-05 | — | — | CN | disclosed |
| CN-120131459-A | Anti-hair loss essence and preparation method thereof | 广东凯乐生物技术有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120131597-A | Alopecia preventing composition and application thereof | 广东凯乐生物技术有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120131597-A | Alopecia preventing composition and application thereof | 广东凯乐生物技术有限公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-0187854-A4 | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR HAIR GROWTH PROMOTION. | BAZZANO GAIL S | 1987-01-22 | — | — | EP | disclosed |
| EP-0187854-A1 | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR HAIR GROWTH PROMOTION | BAZZANO, Gail S (US) | 1986-07-23 | — | — | EP | disclosed |
| WO-1986000616-A1 | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR HAIR GROWTH PROMOTION | BAZZANO GAIL SANSONE | 1986-01-30 | — | — | WO | disclosed |
| US-4393065-A | INCREASED PRODUCTIVITY OF BY-PRODUCTS BY INCLUSION OF PYRIMIDINE COMPOUNDS | THE UPJOHN COMPANY (US) | 1983-07-12 | — | — | US | disclosed |
| EP-0042669-A2 | Compounds and compositions for use in animal feeds | THE UPJOHN COMPANY (US) | 1981-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170239164-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH OR PREVENTING HAIR LOSS | FGF1, CUTA, NGF | HRH4 4355/4885SMN1; SMN2 3796/4885CRHBP 842/4885 |
| US-10016351-B2 | Composition for promoting hair growth or preventing hair loss | FGF1, CUTA, NGF | HRH4 4355/4885SMN1; SMN2 3796/4885CRHBP 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.